Yes, fluticare approval by christmas would be nice, but I'm sure it won't happen and it won't be considered late, until 12/31/17.
Someone else posted on here that INNV investor relations indicated that they are in a quite period, I think it's because they simply don't have anything new to say...It's not that they're in talks regarding being bought out or something, lol.
At the earliest, I think fluticare will be approved in March 2017.
I don't think fluticare approval will result in an increased share price at all...
I don't think fluticare approval will result in any trading halt.
(After all, we're not talking about a life extending or a life trading drug here...)
I think the only way fluticare approval will increase the share price is after a couple/few/several quarters of sales, which include fluticare.
I don't think what I said is negative, I think it's realistic.
Please feel free to explain to me why I am wrong.
When INNV was new and market makers were largely unaware of it, pump press releases would boost the share price double, sometimes triple in a day, but not anymore, the MMs are aware of INNV.
Someone on here needs to find out when GSK submitted to the FDA to make flonase OTC and how long it took them to get approval.
If it took GSK 3 years, to get it OTC approved, maybe it will take INNV 3 years as well and even if it only took GSK 2 years (which is still a long time) due to the big pharma/FDA corruption, they will probably make INNV wait for longer than GSK had to wait.
What do you guys think?
